Independent provider comparison
Updated September 21, 2026
Hers vs Shed: Which GLP-1 provider is better?
A side-by-side look at total cost, medication format, care, commitment and the situations where each option makes more sense.
The decision
Which should you choose, Hers or Shed?
Short answer: Shed scores higher on our published rubric, 7.8/10 against 5.3/10. Published pricing is not a like-for-like monthly comparison: Hers is $188 first month, then $298/mo; Shed is from $159/mo.
Consider Hers if
Women who want a female-focused platform and can budget at least $188 initially and $298/mo ongoing for a $149 medication path.
Consider Shed if
Users who want a price that stays flat as the dose escalates, on a simple compounded GLP-1 program.
Scores follow our published methodology. Partnership status does not change the score or the factual comparison.
Hers
#26 of 37Best for women who want a female-focused platform and can budget at least $188 initially and $298/mo ongoing for a $149 medication path.
Visit Hers
Shed
#7 of 37Best for users who want a price that stays flat as the dose escalates, on a simple compounded glp-1 program.
Visit ShedSide by side
Hers vs Shed at a glance
Compare the price unit as well as the number. A medication-only price, prepaid monthly equivalent and complete recurring program are not the same thing.
| Feature | Hers | Shed |
|---|---|---|
Why each oneHersA major women-focused telehealth platform with a direct Novo Nordisk partnership (Wegovy pill from $149 and pen from $199 before required membership) and a Lilly partnership (Zepbound medication from $299) alongside compounded options. ShedOne flat price at any dose. Shed holds the monthly price steady as the dose escalates, with semaglutide from $159 and tirzepatide from $239 on the 12-month plans and provider care included. | ||
| Our Score | 5.3/10 | 7.8/10 |
| Headline Price | $188 first month, then $298/mo | from $159/mo |
| Medication Type | Both | Both |
| Insurance Accepted | No | No |
Best ForHersWomen who want a female-focused platform and can budget at least $188 initially and $298/mo ongoing for a $149 medication path ShedUsers who want a price that stays flat as the dose escalates, on a simple compounded GLP-1 program | ||
Watch out forHersPending federal enforcement against the parent company: on July 29, 2026 the FTC, joined by Utah and by California acting through Los Angeles County Counsel, sued Hims & Hers Health, Inc. in the Northern District of California over subscription billing, cancellation friction and sharing consumer health information with advertising platforms. The case status is Pending and these are allegations, not findings (checked 2026-09-03). ShedBrand name Wegovy, Zepbound and Foundayo sit behind a separate Shed membership, quoted at $125 a month on all three product pages, with the medication billed on top by the dispensing pharmacy. The small print on the Wegovy and Zepbound pages still says $99, so Shed's own pages disagree on the figure. | ||
| Ranking | #26 | #7 |
| Get started | Visit Hers | Visit Shed |
Trade-offs
Strengths and cautions compared
Hers
Pros
- +Brand-name paths include Wegovy pill, Foundayo, and Ozempic pill medication from $149 and a Wegovy pen from $199. Wegovy and Foundayo carry FDA approval for weight management, Ozempic is approved for type 2 diabetes and is used off label here. With the required membership, a $149 medication path totals $188 initially and $298/mo ongoing
- +Zepbound access via the Lilly/Hims-Hers partnership announced 2026
- +Publicly traded company (NYSE: HIMS) with strong financial backing and regulatory compliance
1 more documented strengths
- +Broader women's health platform, integrates weight loss with hormonal, skin, and wellness services
Cons
- −Pending federal enforcement against the parent company: on July 29, 2026 the FTC, joined by Utah and by California acting through Los Angeles County Counsel, sued Hims & Hers Health, Inc. in the Northern District of California over subscription billing, cancellation friction and sharing consumer health information with advertising platforms. The case status is Pending and these are allegations, not findings (checked 2026-09-03).
- −Every medication figure excludes the required Weight Loss Membership ($39 first month, then $149/mo); exact product and dose prices can increase the total above the $188/$298 floor
- −Support runs at big-platform scale, fine for routine refills, less personal if you want high-touch care
2 more documented cautions
- −Compounded pricing starts at $199/mo with stepped pricing at higher doses, budget for the dose you'll end up on, not the entry dose
- −Zepbound medication starts at $299 before the required membership; that path totals $338 in month one and at least $448/mo ongoing, with exact dose pricing potentially higher
Shed
Pros
- +One flat price at any dose, Shed's pricing page states the monthly price never rises as the dose escalates
- +$199/mo is competitively priced for an all-inclusive compounded program with good support
- +Onboarding is fully online and asynchronous in many states, with same day approval advertised, though Shed says some states require a video visit before treatment
1 more documented strengths
- +Clean, modern UX with real-time shipping tracking and easy provider messaging
Cons
- −Brand name Wegovy, Zepbound and Foundayo sit behind a separate Shed membership, quoted at $125 a month on all three product pages, with the medication billed on top by the dispensing pharmacy. The small print on the Wegovy and Zepbound pages still says $99, so Shed's own pages disagree on the figure.
- −Short track record and thin published outcome data. A founding date is not shown on the site's about, contact, terms or FAQ pages (rendered check 2026-09-03), and the best evidence available is a 4.7 Trustpilot score across 1,129 reviews on a profile claimed in April 2025
- −Shed does not bill insurance, so the compounded program is cash pay, though it accepts HSA and FSA cards, posts downloadable receipts for reimbursement, and includes prior authorization and appeals support on the brand name route
1 more documented cautions
- −Clinical support is responsive (replies typically within 24 hours) but less proactive than premium platforms; a $49.99/mo premium coaching add-on covers those who want higher touch
Our Verdict
Shed edges out Hers with a score of 7.8/10 vs 5.3/10. Published pricing is not a like-for-like monthly comparison: Hers is $188 first month, then $298/mo; Shed is from $159/mo.
Keep narrowing the decision
What should you compare next?
Use the unresolved part of this choice, not a generic related article. These guides own the broader medication, coverage or complete-cost question.
- Pill decisionCompare Wegovy pill prices and accessUse the dedicated guide for dose-specific costs, required memberships and which providers currently list the FDA-approved pill.Continue
- Treatment decisionCompare semaglutide providers and pricesMove from this head-to-head to the broader semaglutide market without confusing compounded products with FDA-approved brands.Continue
- Treatment decisionCompare tirzepatide providers and pricesReview provider options, price units and treatment context across the wider tirzepatide market.Continue
Cheapest complete recurring price in our index
Eden Health GLP-1
$99/mo month-to-month, from $34 on a plan · 6.9/10 · Both
Both Hers and Shed start above the cheapest complete recurring program we track. Across all 37 providers in our index, the lowest price with affirmative medication, consultation, and shipping inclusion is Eden Health GLP-1 at $99/mo, price checked August 28, 2026. It scores 6.9/10 and is not the highest-scored provider in our full rankings, so this is a cost floor rather than a recommendation. Worth knowing before you decide.
Reviews and pricing sources
Not sure which one is right for you?
Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.
Still working out whether either one is above board? We check that separately: is Hers legit and is Shed legit, with the verification evidence behind each answer.
Our pick of these two: Shed · 7.8/10